The regulatory function of SPARC in vascular biology (Q37913130)

25 August 2017

1 reference

title

The regulatory function of SPARC in vascular biology (English)

1 reference

25 August 2017

Lee B Rivera

1

1 reference

PubMed ID

21822645

25 August 2017

Amy D Bradshaw

series ordinal

2

1 reference

PubMed ID

21822645

25 August 2017

Rolf A Brekken

series ordinal

3

1 reference

25 August 2017

6 August 2011

1 reference

Cellular and Molecular Life Sciences

25 August 2017

1 reference

25 August 2017

68

1 reference

25 August 2017

19

1 reference

25 August 2017

3165-3173

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-011-0781-8

25 August 2017

0 references

cites work

Osteonectin, a bone-specific protein linking mineral to collagen

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC, a matricellular protein: at the crossroads of cell-matrix communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Is SPARC an evolutionarily conserved collagen chaperone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Endothelial cell injury in vitro is associated with increased secretion of an Mr 43,000 glycoprotein ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC is a source of copper-binding peptides that stimulate angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

The role of SPARC in extracellular matrix assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Fibroblast growth factor receptor‐1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: A role for protein kinase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Autocrine VEGF signaling is required for vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-beta-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC Inhibits Epithelial Cell Proliferation in Part through Stimulation of the Transforming Growth Factor-β–Signaling System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC enhances tumor stroma formation and prevents fibroblast activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Influence of pericytes on capillary endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Functional atlas of the integrin adhesome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Integrins: the keys to unlocking angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Cell-matrix adhesion in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking alphav integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Integrin and growth factor receptor alliance in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Imaging of integrin alphavbeta3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Vascular integrins in tumor angiogenesis: mediators and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Molecular pathway for cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Secreted protein acidic, rich in cysteine induces pulp cell migration via alphavbeta3 integrin and extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0781-8

Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture

21 January 2018

1 reference

12 December 2020

SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells

1 reference

12 December 2020

Mineral and collagen-binding proteins of fetal calf bone

1 reference

12 December 2020

Heparan sulfate proteoglycans as transducers of FGF-2 signalling.

1 reference

12 December 2020

Regulation of postangiogenic neovessel survival by beta1 and beta3 integrins in collagen and fibrin matrices

1 reference

12 December 2020

SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity

1 reference

12 December 2020

Culture shock. Selective uptake and rapid release of a novel serum protein by endothelial cells in vitro

1 reference

12 December 2020

The synergistic effect of TGF-beta and 1,25-dihydroxyvitamin D3 on SPARC synthesis and alkaline phosphatase activity in human pulp fibroblasts

1 reference

12 December 2020

Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell 'culture shock' glycoprotein of Mr 43,000.

1 reference

12 December 2020

Plasmin, fibrin degradation and angiogenesis

1 reference

12 December 2020

Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice

1 reference

12 December 2020

Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis

1 reference

12 December 2020

10.1007/S00018-011-0781-8

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21822645